China NMPA accepts and grants priority review status to Hutchmed’s NDA for fanregratinib in second-line intrahepatic cholangiocarcinoma: Hong Kong, Shanghai Wednesday, December ...
The first round of our Readers' Choice voting is complete. Find out which products won the Best Camera, Best Prime Lens and ...
Our testing panel reviewed loads of eye-catching B2B technology this year - and these are the 9 coolest gadgets and devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback